Table for the 1,069 triples for predicate <http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/object>

SubjectObject
?:alprazolam_bioavailability_continuous_value?:DB00404
?:alprazolam_has_metabolite_4-hydroxyalprazolam?:DB00404
?:alprazolam_has_metabolite_alpha-hydroxyalprazolam?:DB00404
?:alprazolam_increases_auc_nefazodone?:DB00404
?:alprazolam_increases_auc_selegiline?:DB00404
?:alprazolam_is_not_substrate_of_cyp1a2?:DB00404
?:alprazolam_is_not_substrate_of_cyp3a4?:DB00404
?:alprazolam_is_not_substrate_of_cyp3a5?:DB00404
?:alprazolam_maximum_concentration_continuous_value?:DB00404
?:alprazolam_primary_metabolic_clearance_enzyme_cyp3a4?:DB00404
?:alprazolam_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00404
?:alprazolam_substrate_of_cyp1a2?:DB00404
?:alprazolam_substrate_of_cyp3a4?:DB00404
?:alprazolam_substrate_of_cyp3a5?:DB00404
?:amiodarone_does_not_inhibit_cyp1a2?:DB01118
?:amiodarone_does_not_inhibit_cyp2c9?:DB01118
?:amiodarone_does_not_inhibit_cyp2d6?:DB01118
?:amiodarone_does_not_inhibit_cyp3a4?:DB01118
?:amiodarone_inhibits_cyp1a2?:DB01118
?:amiodarone_inhibits_cyp2c9?:DB01118
?:amiodarone_inhibits_cyp2d6?:DB01118
?:amiodarone_inhibits_cyp3a4?:DB01118
?:aripiprazole_bioavailability_continuous_value?:DB01238
?:aripiprazole_does_not_inhibit_cyp1a2?:DB01238
?:aripiprazole_does_not_inhibit_cyp2c19?:DB01238
?:aripiprazole_does_not_inhibit_cyp2c9?:DB01238
?:aripiprazole_does_not_inhibit_cyp2d6?:DB01238
?:aripiprazole_does_not_inhibit_cyp3a4?:DB01238
?:aripiprazole_has_metabolite_dehydro-aripiprazole?:DB01238
?:aripiprazole_increases_auc_escitalopram?:DB01238
?:aripiprazole_increases_auc_venlafaxine?:DB01238
?:aripiprazole_inhibits_cyp1a2?:DB01238
?:aripiprazole_inhibits_cyp2c19?:DB01238
?:aripiprazole_inhibits_cyp2c9?:DB01238
?:aripiprazole_inhibits_cyp2d6?:DB01238
?:aripiprazole_inhibits_cyp3a4?:DB01238
?:aripiprazole_is_not_substrate_of_cyp1a1?:DB01238
?:aripiprazole_is_not_substrate_of_cyp1a2?:DB01238
?:aripiprazole_is_not_substrate_of_cyp2a6?:DB01238
?:aripiprazole_is_not_substrate_of_cyp2b6?:DB01238
?:aripiprazole_is_not_substrate_of_cyp2c19?:DB01238
?:aripiprazole_is_not_substrate_of_cyp2c8?:DB01238
?:aripiprazole_is_not_substrate_of_cyp2c9?:DB01238
?:aripiprazole_is_not_substrate_of_cyp2d6?:DB01238
?:aripiprazole_is_not_substrate_of_cyp2e1?:DB01238
?:aripiprazole_is_not_substrate_of_cyp3a4?:DB01238
?:aripiprazole_maximum_concentration_continuous_value?:DB01238
?:aripiprazole_primary_total_clearance_mechanism_Metabolic_Clearance?:DB01238
?:aripiprazole_substrate_of_cyp1a1?:DB01238
?:aripiprazole_substrate_of_cyp1a2?:DB01238
?:aripiprazole_substrate_of_cyp2a6?:DB01238
?:aripiprazole_substrate_of_cyp2b6?:DB01238
?:aripiprazole_substrate_of_cyp2c19?:DB01238
?:aripiprazole_substrate_of_cyp2c8?:DB01238
?:aripiprazole_substrate_of_cyp2c9?:DB01238
?:aripiprazole_substrate_of_cyp2d6?:DB01238
?:aripiprazole_substrate_of_cyp2e1?:DB01238
?:aripiprazole_substrate_of_cyp3a4?:DB01238
?:atazanavir_does_not_inhibit_cyp1a2?:DB01072
?:atazanavir_does_not_inhibit_cyp2a6?:DB01072
?:atazanavir_does_not_inhibit_cyp2b6?:DB01072
?:atazanavir_does_not_inhibit_cyp2c19?:DB01072
?:atazanavir_does_not_inhibit_cyp2c9?:DB01072
?:atazanavir_does_not_inhibit_cyp2d6?:DB01072
?:atazanavir_does_not_inhibit_cyp2e1?:DB01072
?:atazanavir_does_not_inhibit_cyp3a4?:DB01072
?:atazanavir_does_not_inhibit_cyp3a5?:DB01072
?:atazanavir_inhibits_cyp1a2?:DB01072
?:atazanavir_inhibits_cyp2a6?:DB01072
?:atazanavir_inhibits_cyp2b6?:DB01072
?:atazanavir_inhibits_cyp2c19?:DB01072
?:atazanavir_inhibits_cyp2c9?:DB01072
?:atazanavir_inhibits_cyp2d6?:DB01072
?:atazanavir_inhibits_cyp2e1?:DB01072
?:atazanavir_inhibits_cyp3a4?:DB01072
?:atazanavir_inhibits_cyp3a5?:DB01072
?:atomoxetine_bioavailability_continuous_value?:DB00289
?:atomoxetine_does_not_inhibit_cyp1a2?:DB00289
?:atomoxetine_does_not_inhibit_cyp2c9?:DB00289
?:atomoxetine_does_not_inhibit_cyp2d6?:DB00289
?:atomoxetine_has_metabolite_4-hydroxyatomoxetine?:DB00289
?:atomoxetine_has_metabolite_N-desmethylatomoxetine?:DB00289
?:atomoxetine_increases_auc_desipramine?:DB00289
?:atomoxetine_inhibits_cyp1a2?:DB00289
?:atomoxetine_inhibits_cyp2c9?:DB00289
?:atomoxetine_inhibits_cyp2d6?:DB00289
?:atomoxetine_primary_total_clearance_enzyme_cyp2d6?:DB00289
?:atomoxetine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00289
?:atorvastatin_bioavailability_continuous_value?:DB01076
?:atorvastatin_does_not_inhibit_cyp3a4?:DB01076
?:atorvastatin_does_not_permanently_deactivate_catalytic_function_cyp2c8?:DB01076
?:atorvastatin_has_metabolite_ortho-hydroxy-atorvastatin?:DB01076
?:atorvastatin_has_metabolite_para-hydroxy-atorvastatin?:DB01076
?:atorvastatin_inhibition_constant_cyp2c8?:DB01076
?:atorvastatin_inhibits_cyp3a4?:DB01076
?:atorvastatin_is_not_substrate_of_cyp1a1?:DB01076
?:atorvastatin_is_not_substrate_of_cyp2b6?:DB01076
?:atorvastatin_is_not_substrate_of_cyp2c19?:DB01076
?:atorvastatin_is_not_substrate_of_cyp2c9?:DB01076
?:atorvastatin_is_not_substrate_of_cyp2d6?:DB01076
?:atorvastatin_is_not_substrate_of_cyp2e1?:DB01076
?:atorvastatin_is_not_substrate_of_cyp3a4?:DB01076
?:atorvastatin_is_not_substrate_of_cyp3a5?:DB01076
?:atorvastatin_maximum_concentration_continuous_value?:DB01076
?:atorvastatin_primary_total_clearance_enzyme_cyp3a4?:DB01076
?:atorvastatin_primary_total_clearance_mechanism_Metabolic_Clearance?:DB01076
?:atorvastatin_substrate_of_cyp1a1?:DB01076
?:atorvastatin_substrate_of_cyp2b6?:DB01076
?:atorvastatin_substrate_of_cyp2c19?:DB01076
?:atorvastatin_substrate_of_cyp2c9?:DB01076
?:atorvastatin_substrate_of_cyp2d6?:DB01076
?:atorvastatin_substrate_of_cyp2e1?:DB01076
?:atorvastatin_substrate_of_cyp3a4?:DB01076
?:atorvastatin_substrate_of_cyp3a5?:DB01076
?:bupropion_does_not_inhibit_cyp2d6?:DB01156
?:bupropion_has_metabolite_erythrohydrobupropion?:DB01156
?:bupropion_has_metabolite_hydroxybupropion?:DB01156
?:bupropion_has_metabolite_threohydrobupropion?:DB01156
?:bupropion_increases_auc_desipramine?:DB01156
?:bupropion_inhibits_cyp2d6?:DB01156
?:bupropion_is_not_substrate_of_cyp2b6?:DB01156
?:bupropion_maximum_concentration_continuous_value?:DB01156
?:bupropion_primary_total_clearance_mechanism_Metabolic_Clearance?:DB01156
?:bupropion_primary_total_clearance_mechanism_Renal_Excretion?:DB01156
?:bupropion_substrate_of_cyp2b6?:DB01156
?:caffeine_primary_total_clearance_enzyme_cyp1a2?:DB00201
?:celecoxib_does_not_inhibit_cyp2c19?:DB00482
?:celecoxib_does_not_inhibit_cyp2c9?:DB00482
?:celecoxib_does_not_inhibit_cyp2d6?:DB00482
?:celecoxib_does_not_inhibit_cyp3a4?:DB00482
?:celecoxib_inhibits_cyp2c19?:DB00482
?:celecoxib_inhibits_cyp2c9?:DB00482
?:celecoxib_inhibits_cyp2d6?:DB00482
?:celecoxib_inhibits_cyp3a4?:DB00482
?:celecoxib_is_not_substrate_of_cyp2c9?:DB00482
?:celecoxib_maximum_concentration_continuous_value?:DB00482
?:celecoxib_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00482
?:celecoxib_substrate_of_cyp2c9?:DB00482
?:chlorpromazine_bioavailability_continuous_value?:DB00477
?:chlorpromazine_does_not_inhibit_cyp2c19?:DB00477
?:chlorpromazine_inhibits_cyp2c19?:DB00477
?:chlorpromazine_maximum_concentration_continuous_value?:DB00477
?:chlorzoxazone_in_vitro_probe_substrate_of_enzyme_cyp2e1?:DB00356
?:cimetidine_does_not_inhibit_cyp1a2?:DB00501
?:cimetidine_does_not_inhibit_cyp3a4?:DB00501
?:cimetidine_does_not_inhibit_cyp3a5?:DB00501
?:cimetidine_increases_auc_amitriptyline?:DB00501
?:cimetidine_increases_auc_citalopram?:DB00501
?:cimetidine_increases_auc_doxepin?:DB00501
?:cimetidine_increases_auc_erythrohydrobupropion?:DB00501
?:cimetidine_increases_auc_escitalopram?:DB00501
?:cimetidine_increases_auc_imipramine?:DB00501
?:cimetidine_increases_auc_mirtazapine?:DB00501
?:cimetidine_increases_auc_nefazodone?:DB00501
?:cimetidine_increases_auc_nortriptyline?:DB00501
?:cimetidine_increases_auc_paroxetine?:DB00501
?:cimetidine_increases_auc_quetiapine?:DB00501
?:cimetidine_increases_auc_sertraline?:DB00501
?:cimetidine_increases_auc_theophylline?:DB00501
?:cimetidine_increases_auc_threohydrobupropion?:DB00501
?:cimetidine_increases_auc_venlafaxine?:DB00501
?:cimetidine_increases_auc_ziprasidone?:DB00501
?:cimetidine_inhibits_cyp1a2?:DB00501
?:cimetidine_inhibits_cyp3a4?:DB00501
?:cimetidine_inhibits_cyp3a5?:DB00501
?:cinacalcet_does_not_inhibit_cyp1a2?:DB01012
?:cinacalcet_does_not_inhibit_cyp2c19?:DB01012
?:cinacalcet_does_not_inhibit_cyp2c9?:DB01012
?:cinacalcet_does_not_inhibit_cyp2d6?:DB01012
?:cinacalcet_does_not_inhibit_cyp3a4?:DB01012
?:cinacalcet_does_not_inhibit_cyp3a5?:DB01012
?:cinacalcet_has_metabolite_hydrocinnamic-acid?:DB01012
?:cinacalcet_has_metabolite_hydroxy-hydrocinnamic-acid?:DB01012
?:cinacalcet_inhibits_cyp1a2?:DB01012
?:cinacalcet_inhibits_cyp2c19?:DB01012
?:cinacalcet_inhibits_cyp2c9?:DB01012
?:cinacalcet_inhibits_cyp2d6?:DB01012
?:cinacalcet_inhibits_cyp3a4?:DB01012
?:cinacalcet_inhibits_cyp3a5?:DB01012
?:cinacalcet_is_not_substrate_of_cyp1a2?:DB01012
?:cinacalcet_is_not_substrate_of_cyp2d6?:DB01012
?:cinacalcet_is_not_substrate_of_cyp3a4?:DB01012
?:cinacalcet_primary_total_clearance_mechanism_Metabolic_Clearance?:DB01012
?:cinacalcet_substrate_of_cyp1a2?:DB01012
?:cinacalcet_substrate_of_cyp2d6?:DB01012
?:cinacalcet_substrate_of_cyp3a4?:DB01012
?:ciprofloxacin_does_not_inhibit_cyp1a2?:DB00537
?:ciprofloxacin_inhibits_cyp1a2?:DB00537
?:citalopram_bioavailability_continuous_value?:DB00215
?:citalopram_does_not_inhibit_cyp2c9?:DB00215
?:citalopram_does_not_inhibit_cyp2e1?:DB00215
?:citalopram_does_not_inhibit_cyp3a4?:DB00215
?:citalopram_has_metabolite_demethylcitalopram?:DB00215
?:citalopram_has_metabolite_didemethylcitalopram?:DB00215
?:citalopram_increases_auc_alprazolam?:DB00215
?:citalopram_increases_auc_desipramine?:DB00215
?:citalopram_increases_auc_selegiline?:DB00215
?:citalopram_inhibits_cyp1a2?:DB00215
?:citalopram_inhibits_cyp2c19?:DB00215
?:citalopram_inhibits_cyp2c9?:DB00215
?:citalopram_inhibits_cyp2d6?:DB00215
?:citalopram_inhibits_cyp2e1?:DB00215
?:citalopram_inhibits_cyp3a4?:DB00215
?:citalopram_is_not_substrate_of_cyp2c19?:DB00215
?:citalopram_is_not_substrate_of_cyp3a4?:DB00215
?:citalopram_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00215
?:citalopram_primary_total_clearance_mechanism_Renal_Excretion?:DB00215
?:citalopram_substrate_of_cyp2c19?:DB00215
?:citalopram_substrate_of_cyp2d6?:DB00215
?:citalopram_substrate_of_cyp3a4?:DB00215
?:clarithromycin_bioavailability_continuous_value?:DB01211
?:clarithromycin_does_not_inhibit_cyp3a4?:DB01211
?:clarithromycin_does_not_inhibit_cyp3a5?:DB01211
?:clarithromycin_does_not_permanently_deactivate_catalytic_function_cyp3a4?:DB01211
?:clarithromycin_fraction_absorbed_continuous_value?:DB01211
?:clarithromycin_has_metabolite_14-hydroxyclarithromycin?:DB01211
?:clarithromycin_in_viVo_selective_inhibitor_of_enzyme_cyp3a4?:DB01211
?:clarithromycin_increases_auc_atorvastatin?:DB01211
?:clarithromycin_increases_auc_lansoprazole?:DB01211
?:clarithromycin_increases_auc_midazolam?:DB01211
?:clarithromycin_increases_auc_pravastatin?:DB01211
?:clarithromycin_increases_auc_trazodone?:DB01211
?:clarithromycin_increases_auc_triazolam?:DB01211
?:clarithromycin_inhibition_constant_cyp3a4?:DB01211
?:clarithromycin_inhibits_cyp3a4?:DB01211
?:clarithromycin_inhibits_cyp3a5?:DB01211
?:clarithromycin_is_not_substrate_of_cyp1a2?:DB01211
?:clarithromycin_is_not_substrate_of_cyp2c9?:DB01211
?:clarithromycin_is_not_substrate_of_cyp2d6?:DB01211
?:clarithromycin_is_not_substrate_of_cyp3a4?:DB01211
?:clarithromycin_maximum_concentration_continuous_value?:DB01211
?:clarithromycin_substrate_of_cyp1a2?:DB01211
?:clarithromycin_substrate_of_cyp2c9?:DB01211
?:clarithromycin_substrate_of_cyp2d6?:DB01211
?:clarithromycin_substrate_of_cyp3a4?:DB01211
?:clopidogrel_increases_auc_bupropion?:DB00758
?:clopidogrel_inhibition_constant_cyp2b6?:DB00758
?:clozapine_does_not_inhibit_cyp2c19?:DB00363
?:clozapine_has_metabolite_7-hydroxyclozapine?:DB00363
?:clozapine_has_metabolite_clozapine-N-oxide?:DB00363
?:clozapine_has_metabolite_desmethylclozapine?:DB00363
?:clozapine_inhibition_constant_cyp2c19?:DB00363
?:clozapine_inhibition_constant_cyp2c9?:DB00363
?:clozapine_inhibition_constant_cyp2d6?:DB00363
?:clozapine_inhibition_constant_cyp3a4?:DB00363
?:clozapine_inhibits_cyp2c19?:DB00363
?:clozapine_is_not_substrate_of_cyp1a2?:DB00363
?:clozapine_is_not_substrate_of_cyp2d6?:DB00363
?:clozapine_is_not_substrate_of_cyp3a4?:DB00363
?:clozapine_maximum_concentration_continuous_value?:DB00363
?:clozapine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00363
?:clozapine_substrate_of_cyp1a2?:DB00363
?:clozapine_substrate_of_cyp2d6?:DB00363
?:clozapine_substrate_of_cyp3a4?:DB00363
?:cyp1a1_controls_formation_of_threohydrobupropion?:PR_000006101
?:cyp1a2_controls_formation_of_3-methylxanthine?:PR_000006102
?:cyp1a2_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine?:PR_000006102
?:cyp1a2_controls_formation_of_N-dealkylperphenazine?:PR_000006102
?:cyp1a2_controls_formation_of_O-desmethylvenlafaxine?:PR_000006102
?:cyp1a2_controls_formation_of_hydroxybupropion?:PR_000006102
?:cyp1a2_controls_formation_of_threohydrobupropion?:PR_000006102
?:cyp1b1_controls_formation_of_threohydrobupropion?:PR_000006103
?:cyp2a13_controls_formation_of_threohydrobupropion?:PR_000006113
?:cyp2a6_controls_formation_of_threohydrobupropion?:PR_000006114
?:cyp2b6_controls_formation_of_hydroxybupropion?:PR_000006116
?:cyp2b6_controls_formation_of_threohydrobupropion?:PR_000006116
?:cyp2c19_controls_formation_of_N-dealkylperphenazine?:PR_000006118
?:cyp2c19_controls_formation_of_N-desmethylatomoxetine?:PR_000006118
?:cyp2c19_controls_formation_of_N-desmethylsertraline?:PR_000006118
?:cyp2c19_controls_formation_of_hydroxybupropion?:PR_000006118
?:cyp2c19_controls_formation_of_threohydrobupropion?:PR_000006118
?:cyp2c19_polymorphic_enzyme_True?:PR_000006118
?:cyp2c8_controls_formation_of_6alpha-hydroxy-paclitaxel?:PR_000006119
?:cyp2c8_controls_formation_of_N-dealkylperphenazine?:PR_000006119
?:cyp2c8_controls_formation_of_threohydrobupropion?:PR_000006119
?:cyp2c9_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine?:PR_000006120
?:cyp2c9_controls_formation_of_N-dealkylperphenazine?:PR_000006120
?:cyp2c9_controls_formation_of_N-desmethylrosuvastatin?:PR_000006120
?:cyp2c9_controls_formation_of_O-desmethylvenlafaxine?:PR_000006120
?:cyp2c9_controls_formation_of_hydroxybupropion?:PR_000006120
?:cyp2c9_controls_formation_of_threohydrobupropion?:PR_000006120
?:cyp2c9_polymorphic_enzyme_True?:PR_000006120
?:cyp2d6_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine?:PR_000006121
?:cyp2d6_controls_formation_of_4-hydroxyatomoxetine?:PR_000006121
?:cyp2d6_controls_formation_of_4-hydroxydebrisoquine?:PR_000006121
?:cyp2d6_controls_formation_of_9-hydroxyrisperidone?:PR_000006121
?:cyp2d6_controls_formation_of_N-dealkylperphenazine?:PR_000006121
?:cyp2d6_controls_formation_of_O-desmethylvenlafaxine?:PR_000006121
?:cyp2d6_controls_formation_of_clozapine-N-oxide?:PR_000006121
?:cyp2d6_controls_formation_of_desmethylclozapine?:PR_000006121
?:cyp2d6_controls_formation_of_hydroxybupropion?:PR_000006121
?:cyp2d6_controls_formation_of_threohydrobupropion?:PR_000006121
?:cyp2d6_polymorphic_enzyme_True?:PR_000006121
?:cyp2e1_controls_formation_of_1,3-dimethyluric-acid?:PR_000006122
?:cyp2e1_controls_formation_of_N-dealkylperphenazine?:PR_000006122
?:cyp2e1_controls_formation_of_threohydrobupropion?:PR_000006122
?:cyp2j2_controls_formation_of_threohydrobupropion?:PR_000006124
?:cyp3a4_controls_formation_of_1'-hydroxymidazolam?:PR_000006130
?:cyp3a4_controls_formation_of_1,3-dimethyluric-acid?:PR_000006130
?:cyp3a4_controls_formation_of_14-hydroxyclarithromycin?:PR_000006130
?:cyp3a4_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine?:PR_000006130
?:cyp3a4_controls_formation_of_4-hydroxyalprazolam?:PR_000006130
?:cyp3a4_controls_formation_of_4-hydroxymidazolam?:PR_000006130
?:cyp3a4_controls_formation_of_6'beta-hydroxy-lovastatin?:PR_000006130
?:cyp3a4_controls_formation_of_N-dealkylperphenazine?:PR_000006130
?:cyp3a4_controls_formation_of_N-desmethyltamoxifen?:PR_000006130
?:cyp3a4_controls_formation_of_N-desmethylvenlafaxine?:PR_000006130
?:cyp3a4_controls_formation_of_alpha-hydroxyalprazolam?:PR_000006130
?:cyp3a4_controls_formation_of_desmethylcitalopram?:PR_000006130
?:cyp3a4_controls_formation_of_ortho-hydroxy-atorvastatin?:PR_000006130
?:cyp3a4_controls_formation_of_para-hydroxy-atorvastatin?:PR_000006130
?:cyp3a4_controls_formation_of_threohydrobupropion?:PR_000006130
?:cyp3a4_controls_formation_of_ziprasidone-sulphoxide?:PR_000006130
?:cyp3a4_polymorphic_enzyme_False?:PR_000006130
?:cyp3a5_controls_formation_of_1'-hydroxymidazolam?:PR_000006132
?:cyp3a5_controls_formation_of_4-hydroxyalprazolam?:PR_000006132
?:cyp3a5_controls_formation_of_4-hydroxymidazolam?:PR_000006132
?:cyp3a5_controls_formation_of_alpha-hydroxyalprazolam?:PR_000006132
?:cyp3a5_controls_formation_of_ortho-hydroxy-atorvastatin?:PR_000006132
?:cyp3a5_controls_formation_of_para-hydroxy-atorvastatin?:PR_000006132
?:cyp3a5_controls_formation_of_threohydrobupropion?:PR_000006132
?:cyp4a11_controls_formation_of_threohydrobupropion?:PR_000006135
?:desipramine_increases_auc_nefazodone?:DB01151
?:desipramine_primary_total_clearance_enzyme_cyp2d6?:DB01151
?:dextromethorphan_in_viVo_probe_substrate_of_enzyme_cyp2d6?:DB00514
?:dextromethorphan_in_vitro_probe_substrate_of_enzyme_cyp2d6?:DB00514
?:dextromethorphan_primary_total_clearance_enzyme_cyp2d6?:DB00514
?:diltiazem_bioavailability_continuous_value?:DB00343
?:diltiazem_does_not_inhibit_cyp3a4?:DB00343
?:diltiazem_has_metabolite_N-demethyldesacetyl-diltiazem?:DB00343
?:diltiazem_has_metabolite_N-demethyldiltiazem?:DB00343
?:diltiazem_has_metabolite_desacetyldiltiazem?:DB00343
?:diltiazem_increases_auc_beta-hydroxy-lovastatin?:DB00343
?:diltiazem_increases_auc_imipramine?:DB00343
?:diltiazem_increases_auc_midazolam?:DB00343
?:diltiazem_increases_auc_pravastatin?:DB00343
?:diltiazem_increases_auc_simvastatin?:DB00343
?:diltiazem_increases_auc_triazolam?:DB00343
?:diltiazem_inhibition_constant_cyp3a4?:DB00343
?:diltiazem_inhibits_cyp3a4?:DB00343
?:diltiazem_is_not_substrate_of_cyp3a4?:DB00343
?:diltiazem_is_not_substrate_of_cyp3a5?:DB00343
?:diltiazem_maximum_concentration_continuous_value?:DB00343
?:diltiazem_permanently_deactivates_catalytic_function_cyp3a4?:DB00343
?:diltiazem_primary_metabolic_clearance_enzyme_cyp2d6?:DB00343
?:diltiazem_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00343
?:diltiazem_substrate_of_cyp3a4?:DB00343
?:diltiazem_substrate_of_cyp3a5?:DB00343
?:diphenhydramine_increases_auc_venlafaxine?:DB01075
?:duloxetine_does_not_inhibit_cyp2c19?:DB00476
?:duloxetine_does_not_inhibit_cyp2c9?:DB00476
?:duloxetine_does_not_inhibit_cyp2d6?:DB00476
?:duloxetine_does_not_inhibit_cyp3a4?:DB00476
?:duloxetine_does_not_inhibit_cyp3a5?:DB00476
?:duloxetine_increases_auc_theophylline?:DB00476
?:duloxetine_inhibits_cyp2c19?:DB00476
?:duloxetine_inhibits_cyp2c9?:DB00476
?:duloxetine_inhibits_cyp2d6?:DB00476
?:duloxetine_inhibits_cyp3a4?:DB00476
?:duloxetine_inhibits_cyp3a5?:DB00476
?:duloxetine_is_not_substrate_of_cyp1a2?:DB00476
?:duloxetine_is_not_substrate_of_cyp2d6?:DB00476
?:duloxetine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00476
?:duloxetine_substrate_of_cyp1a2?:DB00476
?:duloxetine_substrate_of_cyp2d6?:DB00476
?:erythromycin_does_not_inhibit_cyp3a4?:DB00199
?:erythromycin_does_not_permanently_deactivate_catalytic_function_cyp3a4?:DB00199
?:erythromycin_in_viVo_selective_inhibitor_of_enzyme_cyp3a4?:DB00199
?:erythromycin_in_vitro_probe_substrate_of_enzyme_cyp3a4?:DB00199
?:erythromycin_in_vitro_selective_inhibitor_of_enzyme_cyp3a4?:DB00199
?:erythromycin_increases_auc_alprazolam?:DB00199
?:erythromycin_increases_auc_atorvastatin?:DB00199
?:erythromycin_increases_auc_beta-hydroxy-simvastatin?:DB00199
?:erythromycin_increases_auc_fluvastatin?:DB00199
?:erythromycin_increases_auc_midazolam?:DB00199
?:erythromycin_increases_auc_quetiapine?:DB00199
?:erythromycin_increases_auc_risperidone?:DB00199
?:erythromycin_increases_auc_rosuvastatin?:DB00199
?:erythromycin_increases_auc_simvastatin?:DB00199
?:erythromycin_increases_auc_triazolam?:DB00199
?:erythromycin_inhibition_constant_cyp3a4?:DB00199
?:erythromycin_inhibits_cyp3a4?:DB00199
?:escitalopram_bioavailability_continuous_value?:DB01175
?:escitalopram_does_not_inhibit_cyp1a2?:DB01175
?:escitalopram_does_not_inhibit_cyp2c19?:DB01175
?:escitalopram_does_not_inhibit_cyp2c9?:DB01175
?:escitalopram_does_not_inhibit_cyp2d6?:DB01175
?:escitalopram_does_not_inhibit_cyp2e1?:DB01175
?:escitalopram_has_metabolite_S-demethylcitalopram?:DB01175
?:escitalopram_has_metabolite_S-didemethylcitalopram?:DB01175
?:escitalopram_inhibits_cyp1a2?:DB01175
?:escitalopram_inhibits_cyp2c19?:DB01175
?:escitalopram_inhibits_cyp2c9?:DB01175
?:escitalopram_inhibits_cyp2d6?:DB01175
?:escitalopram_inhibits_cyp2e1?:DB01175
?:escitalopram_inhibits_cyp3a4?:DB01175
?:escitalopram_is_not_substrate_of_cyp2c19?:DB01175
?:escitalopram_is_not_substrate_of_cyp2d6?:DB01175
?:escitalopram_is_not_substrate_of_cyp3a4?:DB01175
?:escitalopram_maximum_concentration_continuous_value?:DB01175
?:escitalopram_primary_total_clearance_mechanism_Metabolic_Clearance?:DB01175
?:escitalopram_primary_total_clearance_mechanism_Renal_Excretion?:DB01175
?:escitalopram_substrate_of_cyp2c19?:DB01175
?:escitalopram_substrate_of_cyp2d6?:DB01175
?:escitalopram_substrate_of_cyp3a4?:DB01175
?:eszopiclone_does_not_inhibit_CYP1A2?:DB00402
?:eszopiclone_does_not_inhibit_CYP2A6?:DB00402
?:eszopiclone_does_not_inhibit_CYP2C19?:DB00402
?:eszopiclone_does_not_inhibit_CYP2C9?:DB00402
?:eszopiclone_does_not_inhibit_CYP2D6?:DB00402
?:eszopiclone_does_not_inhibit_CYP2E1?:DB00402
?:eszopiclone_does_not_inhibit_CYP3A4?:DB00402
?:eszopiclone_has_metabolite_S-N-desmethylzopiclone?:DB00402
?:eszopiclone_has_metabolite_S-zopiclone-N-oxide?:DB00402
?:eszopiclone_inhibits_CYP1A2?:DB00402
?:eszopiclone_inhibits_CYP2A6?:DB00402
?:eszopiclone_inhibits_CYP2C19?:DB00402
?:eszopiclone_inhibits_CYP2C9?:DB00402
?:eszopiclone_inhibits_CYP2D6?:DB00402
?:eszopiclone_inhibits_CYP2E1?:DB00402
?:eszopiclone_inhibits_CYP3A4?:DB00402
?:eszopiclone_is_not_substrate_of_cyp3a4?:DB00402
?:eszopiclone_primary_total_clearance_mechanism_Renal_Excretion?:DB00402
?:eszopiclone_substrate_of_cyp2e1?:DB00402
?:eszopiclone_substrate_of_cyp3a4?:DB00402
?:fluconazole_bioavailability_continuous_value?:DB00196
?:fluconazole_does_not_inhibit_cyp2c9?:DB00196
?:fluconazole_does_not_inhibit_cyp3a4?:DB00196
?:fluconazole_does_not_inhibit_cyp3a5?:DB00196
?:fluconazole_increases_auc_fluvastatin?:DB00196
?:fluconazole_increases_auc_midazolam?:DB00196
?:fluconazole_increases_auc_pravastatin?:DB00196
?:fluconazole_increases_auc_rosuvastatin?:DB00196
?:fluconazole_increases_auc_triazolam?:DB00196
?:fluconazole_increases_auc_zolpidem?:DB00196
?:fluconazole_inhibition_constant_cyp3a4?:DB00196
?:fluconazole_inhibits_cyp2c9?:DB00196
?:fluconazole_inhibits_cyp3a4?:DB00196
?:fluconazole_inhibits_cyp3a5?:DB00196
?:fluconazole_maximum_concentration_continuous_value?:DB00196
?:fluconazole_primary_total_clearance_mechanism_Renal_Excretion?:DB00196
?:fluoxetine_does_not_inhibit_cyp2d6?:DB00472
?:fluoxetine_has_metabolite_norfluoxetine?:DB00472
?:fluoxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6?:DB00472
?:fluoxetine_increases_auc_alprazolam?:DB00472
?:fluoxetine_increases_auc_desipramine?:DB00472
?:fluoxetine_increases_auc_imipramine?:DB00472
?:fluoxetine_increases_auc_olanzapine?:DB00472
?:fluoxetine_increases_auc_propafenone?:DB00472
?:fluoxetine_inhibition_constant_cyp3a4?:DB00472
?:fluoxetine_inhibits_cyp2d6?:DB00472
?:fluoxetine_is_not_substrate_of_cyp2d6?:DB00472
?:fluoxetine_maximum_concentration_continuous_value?:DB00472
?:fluoxetine_permanently_deactivates_catalytic_function_cyp2d6?:DB00472
?:fluoxetine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00472
?:fluoxetine_substrate_of_cyp2d6?:DB00472
?:fluphenazine_bioavailability_continuous_value?:DB00623
?:fluphenazine_does_not_inhibit_cyp2c19?:DB00623
?:fluphenazine_inhibition_constant_cyp1a2?:DB00623
?:fluphenazine_inhibition_constant_cyp2d6?:DB00623
?:fluphenazine_inhibits_cyp2c19?:DB00623
?:fluphenazine_maximum_concentration_continuous_value?:DB00623
?:fluvastatin_bioavailability_continuous_value?:DB01095
?:fluvastatin_does_not_permanently_deactivate_catalytic_function_cyp2c8?:DB01095
?:fluvastatin_inhibition_constant_cyp2c8?:DB01095
?:fluvastatin_is_not_substrate_of_cyp2c8?:DB01095
?:fluvastatin_is_not_substrate_of_cyp2c9?:DB01095
?:fluvastatin_is_not_substrate_of_cyp3a4?:DB01095
?:fluvastatin_maximum_concentration_continuous_value?:DB01095
?:fluvastatin_primary_total_clearance_enzyme_cyp2c9?:DB01095
?:fluvastatin_primary_total_clearance_mechanism_Metabolic_Clearance?:DB01095
?:fluvastatin_substrate_of_cyp2c8?:DB01095
?:fluvastatin_substrate_of_cyp2c9?:DB01095
?:fluvastatin_substrate_of_cyp3a4?:DB01095
?:fluvoxamine_bioavailability_continuous_value?:DB00176
?:fluvoxamine_does_not_inhibit_cyp1a2?:DB00176
?:fluvoxamine_does_not_inhibit_cyp2c19?:DB00176
?:fluvoxamine_does_not_inhibit_cyp2c9?:DB00176
?:fluvoxamine_in_vitro_selective_inhibitor_of_enzyme_cyp1a2?:DB00176
?:fluvoxamine_increases_auc_amitriptyline?:DB00176
?:fluvoxamine_increases_auc_clozapine?:DB00176
?:fluvoxamine_increases_auc_duloxetine?:DB00176
?:fluvoxamine_increases_auc_lansoprazole?:DB00176
?:fluvoxamine_increases_auc_mexiletine?:DB00176
?:fluvoxamine_increases_auc_omeprazole?:DB00176
?:fluvoxamine_increases_auc_quinidine?:DB00176
?:fluvoxamine_increases_auc_theophylline?:DB00176
?:fluvoxamine_increases_auc_thioridazine?:DB00176
?:fluvoxamine_increases_auc_tolbutamide?:DB00176
?:fluvoxamine_inhibition_constant_cyp1a2?:DB00176
?:fluvoxamine_inhibits_cyp1a2?:DB00176
?:fluvoxamine_inhibits_cyp2c19?:DB00176
?:fluvoxamine_inhibits_cyp2c9?:DB00176
?:fluvoxamine_is_not_substrate_of_cyp2d6?:DB00176
?:fluvoxamine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00176
?:fluvoxamine_substrate_of_cyp2d6?:DB00176
?:gemfibrozil_does_not_inhibit_cyp2c8?:DB01241
?:gemfibrozil_inhibits_cyp2c8?:DB01241
?:haloperidol_does_not_inhibit_cyp2c19?:DB00502
?:haloperidol_has_metabolite_4-(4-chlorophenyl)-4-hydroxypiperidine?:DB00502
Skipped 69 rows
?:lansoprazole_is_not_substrate_of_cyp2c19?:DB00448
?:lansoprazole_is_not_substrate_of_cyp3a4?:DB00448
?:lansoprazole_is_not_substrate_of_cyp3a5?:DB00448
?:lansoprazole_maximum_concentration_continuous_value?:DB00448
?:lansoprazole_primary_total_clearance_enzyme_cyp2c19?:DB00448
?:lansoprazole_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00448
?:lansoprazole_substrate_of_cyp2c19?:DB00448
?:lansoprazole_substrate_of_cyp3a4?:DB00448
?:lansoprazole_substrate_of_cyp3a5?:DB00448
?:leflunomide_has_metabolite_teriflunomide?:DB01097
?:lovastatin_bioavailability_continuous_value?:DB00227
?:lovastatin_does_not_permanently_deactivate_catalytic_function_cyp2c8?:DB00227
?:lovastatin_first_pass_effect_continuous_value?:DB00227
?:lovastatin_has_metabolite_beta-hydroxy-lovastatin?:DB00227
?:lovastatin_inhibition_constant_cyp2c8?:DB00227
?:lovastatin_is_not_substrate_of_cyp3a4?:DB00227
?:lovastatin_maximum_concentration_continuous_value?:DB00227
?:lovastatin_primary_total_clearance_enzyme_cyp3a4?:DB00227
?:lovastatin_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00227
?:lovastatin_substrate_of_cyp3a4?:DB00227
?:mephenytoin_in_viVo_probe_substrate_of_enzyme_cyp2c19?:DB00532
?:metronidazole_maximum_concentration_continuous_value?:DB00916
?:metronidazole_primary_total_clearance_mechanism_Renal_Excretion?:DB00916
?:mexiletine_does_not_inhibit_cyp1a2?:DB00379
?:mexiletine_inhibits_cyp1a2?:DB00379
?:midazolam_has_metabolite_1'-hydroxymidazolam?:DB00683
?:midazolam_has_metabolite_4-hydroxymidazolam?:DB00683
?:midazolam_in_vitro_probe_substrate_of_enzyme_cyp3a4?:DB00683
?:midazolam_is_not_substrate_of_cyp3a5?:DB00683
?:midazolam_primary_total_clearance_enzyme_cyp3a4?:DB00683
?:midazolam_substrate_of_cyp3a5?:DB00683
?:midodrine_bioavailability_continuous_value?:DB00211
?:midodrine_has_metabolite_desglymidodrine?:DB00211
?:midodrine_primary_total_clearance_mechanism_Renal_Excretion?:DB00211
?:mirtazapine_bioavailability_continuous_value?:DB00370
?:mirtazapine_does_not_inhibit_cyp1a2?:DB00370
?:mirtazapine_does_not_inhibit_cyp2c19?:DB00370
?:mirtazapine_does_not_inhibit_cyp2c9?:DB00370
?:mirtazapine_does_not_inhibit_cyp2d6?:DB00370
?:mirtazapine_does_not_inhibit_cyp2e1?:DB00370
?:mirtazapine_fraction_absorbed_continuous_value?:DB00370
?:mirtazapine_increases_auc_paroxetine?:DB00370
?:mirtazapine_inhibits_cyp1a2?:DB00370
?:mirtazapine_inhibits_cyp2c19?:DB00370
?:mirtazapine_inhibits_cyp2c9?:DB00370
?:mirtazapine_inhibits_cyp2d6?:DB00370
?:mirtazapine_inhibits_cyp2e1?:DB00370
?:mirtazapine_is_not_substrate_of_cyp1a2?:DB00370
?:mirtazapine_is_not_substrate_of_cyp2a6?:DB00370
?:mirtazapine_is_not_substrate_of_cyp2b6?:DB00370
?:mirtazapine_is_not_substrate_of_cyp2c19?:DB00370
?:mirtazapine_is_not_substrate_of_cyp2d6?:DB00370
?:mirtazapine_is_not_substrate_of_cyp2e1?:DB00370
?:mirtazapine_is_not_substrate_of_cyp3a4?:DB00370
?:mirtazapine_is_not_substrate_of_cyp3a5?:DB00370
?:mirtazapine_substrate_of_cyp1a2?:DB00370
?:mirtazapine_substrate_of_cyp2a6?:DB00370
?:mirtazapine_substrate_of_cyp2b6?:DB00370
?:mirtazapine_substrate_of_cyp2c19?:DB00370
?:mirtazapine_substrate_of_cyp2d6?:DB00370
?:mirtazapine_substrate_of_cyp2e1?:DB00370
?:mirtazapine_substrate_of_cyp3a4?:DB00370
?:mirtazapine_substrate_of_cyp3a5?:DB00370
?:modafinil_does_not_inhibit_cyp2c19?:DB00745
?:modafinil_has_metabolite_modafinil-sulfone?:DB00745
?:modafinil_inhibits_cyp2c19?:DB00745
?:modafinil_is_not_substrate_of_cyp3a4?:DB00745
?:modafinil_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00745
?:modafinil_substrate_of_cyp3a4?:DB00745
?:molindone_primary_total_clearance_mechanism_Metabolic_Clearance?:DB01618
?:montelukast_does_not_inhibit_cyp1a2?:DB00471
?:montelukast_does_not_inhibit_cyp2a6?:DB00471
?:montelukast_does_not_inhibit_cyp2c19?:DB00471
?:montelukast_does_not_inhibit_cyp2c8?:DB00471
?:montelukast_does_not_inhibit_cyp2c9?:DB00471
?:montelukast_does_not_inhibit_cyp2d6?:DB00471
?:montelukast_does_not_inhibit_cyp3a4?:DB00471
?:montelukast_inhibition_constant_cyp2c8?:DB00471
?:montelukast_inhibits_cyp1a2?:DB00471
?:montelukast_inhibits_cyp2a6?:DB00471
?:montelukast_inhibits_cyp2c19?:DB00471
?:montelukast_inhibits_cyp2c8?:DB00471
?:montelukast_inhibits_cyp2c9?:DB00471
?:montelukast_inhibits_cyp2d6?:DB00471
?:montelukast_inhibits_cyp3a4?:DB00471
?:nefazodone_does_not_inhibit_cyp1a2?:DB01149
?:nefazodone_does_not_inhibit_cyp3a4?:DB01149
?:nefazodone_does_not_inhibit_cyp3a5?:DB01149
?:nefazodone_in_viVo_selective_inhibitor_of_enzyme_cyp3a4?:DB01149
?:nefazodone_increases_auc_alprazolam?:DB01149
?:nefazodone_increases_auc_midazolam?:DB01149
?:nefazodone_increases_auc_triazolam?:DB01149
?:nefazodone_inhibits_cyp1a2?:DB01149
?:nefazodone_inhibits_cyp3a4?:DB01149
?:nefazodone_inhibits_cyp3a5?:DB01149
?:nefazodone_is_not_substrate_of_cyp1a2?:DB01149
?:nefazodone_is_not_substrate_of_cyp2c19?:DB01149
?:nefazodone_is_not_substrate_of_cyp2c8?:DB01149
?:nefazodone_is_not_substrate_of_cyp2c9?:DB01149
?:nefazodone_is_not_substrate_of_cyp2d6?:DB01149
?:nefazodone_is_not_substrate_of_cyp3a4?:DB01149
?:nefazodone_substrate_of_cyp1a2?:DB01149
?:nefazodone_substrate_of_cyp2c19?:DB01149
?:nefazodone_substrate_of_cyp2c8?:DB01149
?:nefazodone_substrate_of_cyp2c9?:DB01149
?:nefazodone_substrate_of_cyp2d6?:DB01149
?:nefazodone_substrate_of_cyp3a4?:DB01149
?:nicardipine_bioavailability_continuous_value?:DB00622
?:norfloxacin_does_not_inhibit_cyp1a2?:DB01059
?:norfloxacin_inhibits_cyp1a2?:DB01059
?:olanzapine_has_metabolite_10-N-glucuronide?:DB00334
?:olanzapine_increases_auc_selegiline?:DB00334
?:olanzapine_inhibition_constant_cyp2c19?:DB00334
?:olanzapine_inhibition_constant_cyp2c9?:DB00334
?:olanzapine_inhibition_constant_cyp3a4?:DB00334
?:olanzapine_is_not_substrate_of_cyp2d6?:DB00334
?:olanzapine_maximum_concentration_continuous_value?:DB00334
?:olanzapine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00334
?:olanzapine_primary_total_clearance_mechanism_Renal_Excretion?:DB00334
?:olanzapine_substrate_of_cyp2d6?:DB00334
?:omeprazole_does_not_inhibit_cyp2c19?:DB00338
?:omeprazole_does_not_inhibit_cyp2d6?:DB00338
?:omeprazole_in_vitro_probe_substrate_of_enzyme_cyp2c19?:DB00338
?:omeprazole_in_vitro_selective_inhibitor_of_enzyme_cyp2c19?:DB00338
?:omeprazole_increases_auc_escitalopram?:DB00338
?:omeprazole_inhibits_cyp2c19?:DB00338
?:omeprazole_inhibits_cyp2d6?:DB00338
?:omeprazole_primary_total_clearance_enzyme_cyp2c19?:DB00338
?:paclitaxel_has_metabolite_6alpha-hydroxy-paclitaxel?:DB01229
?:paclitaxel_in_vitro_probe_substrate_of_enzyme_cyp2c8?:DB01229
?:paliperidone_bioavailability_continuous_value?:DB01267
?:paliperidone_does_not_inhibit_cyp1a2?:DB01267
?:paliperidone_does_not_inhibit_cyp2a6?:DB01267
?:paliperidone_does_not_inhibit_cyp2c19?:DB01267
?:paliperidone_does_not_inhibit_cyp2c8?:DB01267
?:paliperidone_does_not_inhibit_cyp2c9?:DB01267
?:paliperidone_does_not_inhibit_cyp2d6?:DB01267
?:paliperidone_does_not_inhibit_cyp2e1?:DB01267
?:paliperidone_does_not_inhibit_cyp3a4?:DB01267
?:paliperidone_does_not_inhibit_cyp3a5?:DB01267
?:paliperidone_inhibition_constant_cyp2d6?:DB01267
?:paliperidone_inhibits_cyp1a2?:DB01267
?:paliperidone_inhibits_cyp2a6?:DB01267
?:paliperidone_inhibits_cyp2c19?:DB01267
?:paliperidone_inhibits_cyp2c8?:DB01267
?:paliperidone_inhibits_cyp2c9?:DB01267
?:paliperidone_inhibits_cyp2d6?:DB01267
?:paliperidone_inhibits_cyp2e1?:DB01267
?:paliperidone_inhibits_cyp3a4?:DB01267
?:paliperidone_inhibits_cyp3a5?:DB01267
?:paliperidone_primary_total_clearance_mechanism_Renal_Excretion?:DB01267
?:pantoprazole_bioavailability_continuous_value?:DB00213
?:pantoprazole_does_not_inhibit_cyp2d6?:DB00213
?:pantoprazole_inhibits_cyp2d6?:DB00213
?:pantoprazole_is_not_substrate_of_cyp2c19?:DB00213
?:pantoprazole_is_not_substrate_of_cyp3a4?:DB00213
?:pantoprazole_maximum_concentration_continuous_value?:DB00213
?:pantoprazole_primary_total_clearance_enzyme_cyp2c19?:DB00213
?:pantoprazole_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00213
?:pantoprazole_primary_total_clearance_mechanism_Renal_Excretion?:DB00213
?:pantoprazole_substrate_of_cyp2c19?:DB00213
?:pantoprazole_substrate_of_cyp3a4?:DB00213
?:paroxetine_does_not_inhibit_cyp2d6?:DB00715
?:paroxetine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6?:DB00715
?:paroxetine_in_vitro_selective_inhibitor_of_enzyme_cyp2d6?:DB00715
?:paroxetine_increases_auc_desipramine?:DB00715
?:paroxetine_increases_auc_duloxetine?:DB00715
?:paroxetine_increases_auc_imipramine?:DB00715
?:paroxetine_increases_auc_mirtazapine?:DB00715
?:paroxetine_increases_auc_nortriptyline?:DB00715
?:paroxetine_increases_auc_paliperidone?:DB00715
?:paroxetine_increases_auc_risperidone?:DB00715
?:paroxetine_inhibits_cyp2d6?:DB00715
?:paroxetine_is_not_substrate_of_cyp2d6?:DB00715
?:paroxetine_permanently_deactivates_catalytic_function_cyp2d6?:DB00715
?:paroxetine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00715
?:paroxetine_substrate_of_cyp2d6?:DB00715
?:perphenazine_does_not_inhibit_cyp2c19?:DB00850
?:perphenazine_has_metabolite_7-hydroxyperphenazine?:DB00850
?:perphenazine_inhibition_constant_cyp1a2?:DB00850
?:perphenazine_inhibition_constant_cyp2d6?:DB00850
?:perphenazine_inhibits_cyp2c19?:DB00850
?:perphenazine_is_not_substrate_of_cyp1a2?:DB00850
?:perphenazine_is_not_substrate_of_cyp2c19?:DB00850
?:perphenazine_is_not_substrate_of_cyp2d6?:DB00850
?:perphenazine_is_not_substrate_of_cyp3a4?:DB00850
?:perphenazine_maximum_concentration_continuous_value?:DB00850
?:perphenazine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00850
?:perphenazine_substrate_of_cyp1a2?:DB00850
?:perphenazine_substrate_of_cyp2c19?:DB00850
?:perphenazine_substrate_of_cyp2d6?:DB00850
?:perphenazine_substrate_of_cyp3a4?:DB00850
?:phenacetin_in_vitro_probe_substrate_of_enzyme_cyp1a2?:DB03783
?:pioglitazone_inhibition_constant_cyp2c8?:DB01132
?:pravastatin_does_not_inhibit_cyp2c8?:DB00175
?:pravastatin_has_metabolite_3alpha-hydroxypravastatin?:DB00175
?:pravastatin_inhibits_cyp2c8?:DB00175
?:pravastatin_primary_total_clearance_mechanism_Renal_Excretion?:DB00175
?:propafenone_does_not_inhibit_cyp1a2?:DB01182
?:propafenone_inhibits_cyp1a2?:DB01182
?:propoxyphene_has_metabolite_norpropoxyphene?:DB00647
?:quetiapine_does_not_inhibit_cyp1a2?:DB01224
?:quetiapine_does_not_inhibit_cyp2c19?:DB01224
?:quetiapine_does_not_inhibit_cyp2c9?:DB01224
?:quetiapine_does_not_inhibit_cyp2d6?:DB01224
?:quetiapine_does_not_inhibit_cyp3a4?:DB01224
?:quetiapine_has_metabolite_7-hydroxy-N-desalkyl-quetiapine?:DB01224
?:quetiapine_has_metabolite_7-hydroxy-quetiapine?:DB01224
?:quetiapine_has_metabolite_N-desalkylquetiapine?:DB01224
?:quetiapine_has_metabolite_quetiapine-sulfoxide?:DB01224
?:quetiapine_inhibits_cyp1a2?:DB01224
?:quetiapine_inhibits_cyp2c19?:DB01224
?:quetiapine_inhibits_cyp2c9?:DB01224
?:quetiapine_inhibits_cyp2d6?:DB01224
?:quetiapine_inhibits_cyp3a4?:DB01224
?:quetiapine_is_not_substrate_of_cyp1a2?:DB01224
?:quetiapine_is_not_substrate_of_cyp2c19?:DB01224
?:quetiapine_is_not_substrate_of_cyp2c9?:DB01224
?:quetiapine_is_not_substrate_of_cyp2e1?:DB01224
?:quetiapine_is_not_substrate_of_cyp3a4?:DB01224
?:quetiapine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB01224
?:quetiapine_substrate_of_cyp1a2?:DB01224
?:quetiapine_substrate_of_cyp2c19?:DB01224
?:quetiapine_substrate_of_cyp2c9?:DB01224
?:quetiapine_substrate_of_cyp2e1?:DB01224
?:quetiapine_substrate_of_cyp3a4?:DB01224
?:quinidine_does_not_inhibit_cyp2d6?:DB00908
?:quinidine_in_viVo_selective_inhibitor_of_enzyme_cyp2d6?:DB00908
?:quinidine_in_vitro_selective_inhibitor_of_enzyme_cyp2d6?:DB00908
?:quinidine_increases_auc_venlafaxine?:DB00908
?:quinidine_inhibits_cyp2d6?:DB00908
?:quinidine_permanently_deactivates_catalytic_function_cyp2d6?:DB00908
?:rabeprazole_bioavailability_continuous_value?:DB01129
?:rabeprazole_is_not_substrate_of_cyp2c19?:DB01129
?:rabeprazole_is_not_substrate_of_cyp3a4?:DB01129
?:rabeprazole_is_not_substrate_of_cyp3a5?:DB01129
?:rabeprazole_primary_total_clearance_mechanism_Metabolic_Clearance?:DB01129
?:rabeprazole_substrate_of_cyp2c19?:DB01129
?:rabeprazole_substrate_of_cyp3a4?:DB01129
?:rabeprazole_substrate_of_cyp3a5?:DB01129
?:ranolazine_does_not_inhibit_cyp2d6?:DB00243
?:ranolazine_does_not_inhibit_cyp3a4?:DB00243
?:ranolazine_does_not_inhibit_cyp3a5?:DB00243
?:ranolazine_inhibits_cyp2d6?:DB00243
?:ranolazine_inhibits_cyp3a4?:DB00243
?:ranolazine_inhibits_cyp3a5?:DB00243
?:ranolazine_is_not_substrate_of_cyp2d6?:DB00243
?:ranolazine_maximum_concentration_continuous_value?:DB00243
?:ranolazine_primary_total_clearance_enzyme_cyp3a4?:DB00243
?:ranolazine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00243
?:ranolazine_substrate_of_cyp2d6?:DB00243
?:risperidone_bioavailability_continuous_value?:DB00734
?:risperidone_does_not_inhibit_cyp2c19?:DB00734
?:risperidone_has_metabolite_9-hydroxyrisperidone?:DB00734
?:risperidone_increases_auc_erythromycin?:DB00734
?:risperidone_increases_auc_quetiapine?:DB00734
?:risperidone_increases_auc_selegiline?:DB00734
?:risperidone_inhibition_constant_cyp2d6?:DB00734
?:risperidone_inhibits_cyp2c19?:DB00734
?:risperidone_is_not_substrate_of_cyp2d6?:DB00734
?:risperidone_is_not_substrate_of_cyp3a4?:DB00734
?:risperidone_maximum_concentration_continuous_value?:DB00734
?:risperidone_primary_metabolic_clearance_enzyme_cyp2d6?:DB00734
?:risperidone_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00734
?:risperidone_substrate_of_cyp2d6?:DB00734
?:risperidone_substrate_of_cyp3a4?:DB00734
?:ritonavir_does_not_inhibit_cyp2d6?:DB00503
?:ritonavir_does_not_inhibit_cyp3a4?:DB00503
?:ritonavir_does_not_inhibit_cyp3a5?:DB00503
?:ritonavir_increases_auc_bupropion?:DB00503
?:ritonavir_increases_auc_trazodone?:DB00503
?:ritonavir_inhibits_cyp2d6?:DB00503
?:ritonavir_inhibits_cyp3a4?:DB00503
?:ritonavir_inhibits_cyp3a5?:DB00503
?:rosiglitazone_does_not_inhibit_cyp1a1?:DB00412
?:rosiglitazone_does_not_inhibit_cyp1a2?:DB00412
?:rosiglitazone_does_not_inhibit_cyp2a6?:DB00412
?:rosiglitazone_does_not_inhibit_cyp2b6?:DB00412
?:rosiglitazone_does_not_inhibit_cyp2c19?:DB00412
?:rosiglitazone_does_not_inhibit_cyp2c8?:DB00412
?:rosiglitazone_does_not_inhibit_cyp2c9?:DB00412
?:rosiglitazone_does_not_inhibit_cyp2d6?:DB00412
?:rosiglitazone_does_not_inhibit_cyp2e1?:DB00412
?:rosiglitazone_does_not_inhibit_cyp3a4?:DB00412
?:rosiglitazone_does_not_inhibit_cyp3a5?:DB00412
?:rosiglitazone_inhibition_constant_cyp2c8?:DB00412
?:rosiglitazone_inhibits_cyp1a1?:DB00412
?:rosiglitazone_inhibits_cyp1a2?:DB00412
?:rosiglitazone_inhibits_cyp2a6?:DB00412
?:rosiglitazone_inhibits_cyp2b6?:DB00412
?:rosiglitazone_inhibits_cyp2c19?:DB00412
?:rosiglitazone_inhibits_cyp2c8?:DB00412
?:rosiglitazone_inhibits_cyp2c9?:DB00412
?:rosiglitazone_inhibits_cyp2d6?:DB00412
?:rosiglitazone_inhibits_cyp2e1?:DB00412
?:rosiglitazone_inhibits_cyp3a4?:DB00412
?:rosiglitazone_inhibits_cyp3a5?:DB00412
?:rosiglitazone_primary_total_clearance_enzyme_cyp2c8?:DB00412
?:rosuvastatin_bioavailability_continuous_value?:DB01098
?:rosuvastatin_does_not_inhibit_cyp2c8?:DB01098
?:rosuvastatin_fraction_absorbed_continuous_value?:DB01098
?:rosuvastatin_has_metabolite_N-desmethylrosuvastatin?:DB01098
?:rosuvastatin_inhibits_cyp2c8?:DB01098
?:rosuvastatin_is_not_substrate_of_cyp3a4?:DB01098
?:rosuvastatin_maximum_concentration_continuous_value?:DB01098
?:rosuvastatin_primary_metabolic_clearance_enzyme_cyp2c9?:DB01098
?:rosuvastatin_primary_total_clearance_mechanism_Biliary_Excretion?:DB01098
?:rosuvastatin_substrate_of_cyp3a4?:DB01098
?:sertraline_does_not_inhibit_cyp2d6?:DB01104
?:sertraline_has_metabolite_N-desmethylsertraline?:DB01104
?:sertraline_increases_auc_alprazolam?:DB01104
?:sertraline_increases_auc_clozapine?:DB01104
?:sertraline_increases_auc_clozapine-N-oxide?:DB01104
?:sertraline_increases_auc_desipramine?:DB01104
?:sertraline_increases_auc_desmethylclozapine?:DB01104
?:sertraline_increases_auc_zolpidem?:DB01104
?:sertraline_inhibits_cyp2d6?:DB01104
?:sertraline_is_not_substrate_of_cyp2c19?:DB01104
?:sertraline_substrate_of_cyp2c19?:DB01104
?:sildenafil_primary_total_clearance_enzyme_cyp3a4?:DB00203
?:simvastatin_does_not_inhibit_cyp3a4?:DB00641
?:simvastatin_does_not_permanently_deactivate_catalytic_function_cyp2c8?:DB00641
?:simvastatin_has_metabolite_beta-hydroxy-simvastatin?:DB00641
?:simvastatin_inhibition_constant_cyp2c8?:DB00641
?:simvastatin_inhibits_cyp3a4?:DB00641
?:simvastatin_is_not_substrate_of_cyp3a4?:DB00641
?:simvastatin_primary_total_clearance_enzyme_cyp3a4?:DB00641
?:simvastatin_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00641
?:simvastatin_substrate_of_cyp3a4?:DB00641
?:sulfinpyrazone_in_vitro_selective_inhibitor_of_enzyme_cyp2c9?:DB01138
?:tamoxifen_has_metabolite_4-hydroxytamoxifin?:DB00675
?:tamoxifen_has_metabolite_N-desmethyltamoxifen?:DB00675
?:tamoxifen_is_not_substrate_of_cyp2c9?:DB00675
?:tamoxifen_is_not_substrate_of_cyp2d6?:DB00675
?:tamoxifen_is_not_substrate_of_cyp3a4?:DB00675
?:tamoxifen_is_not_substrate_of_cyp3a5?:DB00675
?:tamoxifen_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00675
?:tamoxifen_substrate_of_cyp2c9?:DB00675
?:tamoxifen_substrate_of_cyp2d6?:DB00675
?:tamoxifen_substrate_of_cyp3a4?:DB00675
?:tamoxifen_substrate_of_cyp3a5?:DB00675
?:telithromycin_does_not_inhibit_cyp3a4?:DB00976
?:telithromycin_does_not_inhibit_cyp3a5?:DB00976
?:telithromycin_inhibits_cyp3a4?:DB00976
?:telithromycin_inhibits_cyp3a5?:DB00976
?:terbinafine_does_not_inhibit_cyp2d6?:DB00857
?:terbinafine_increases_auc_paroxetine?:DB00857
?:terbinafine_increases_auc_venlafaxine?:DB00857
?:terbinafine_inhibits_cyp2d6?:DB00857
?:testosterone_in_vitro_probe_substrate_of_enzyme_cyp3a4?:DB00624
?:theophylline_has_metabolite_1,3-dimethyluric-acid?:DB00277
?:theophylline_has_metabolite_1-methylxanthine?:DB00277
?:theophylline_has_metabolite_3-methylxanthine?:DB00277
?:theophylline_has_metabolite_caffeine?:DB00277
?:theophylline_in_vitro_probe_substrate_of_enzyme_cyp1a2?:DB00277
?:theophylline_primary_total_clearance_enzyme_cyp1a2?:DB00277
?:theophylline_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00277
?:thioridazine_does_not_inhibit_cyp2c19?:DB00679
?:thioridazine_has_metabolite_mesoridazine?:DB00679
?:thioridazine_has_metabolite_sulforidazine?:DB00679
?:thioridazine_has_metabolite_thioridazine-5-sulfoxide?:DB00679
?:thioridazine_inhibition_constant_cyp2d6?:DB00679
?:thioridazine_inhibits_cyp2c19?:DB00679
?:thioridazine_is_not_substrate_of_cyp2d6?:DB00679
?:thioridazine_primary_total_clearance_enzyme_cyp2d6?:DB00679
?:thioridazine_substrate_of_cyp2d6?:DB00679
?:thiothixene_does_not_inhibit_cyp2c19?:DB01623
?:thiothixene_inhibition_constant_cyp2d6?:DB01623
?:thiothixene_inhibits_cyp2c19?:DB01623
?:ticlopidine_increases_auc_bupropion?:DB00208
?:ticlopidine_inhibition_constant_cyp2b6?:DB00208
?:ticlopidine_inhibition_constant_cyp2c19?:DB00208
?:tolbutamide_in_vitro_probe_substrate_of_enzyme_cyp2c9?:DB01124
?:tolbutamide_primary_total_clearance_enzyme_cyp2c9?:DB01124
?:topiramate_does_not_inhibit_cyp1a2?:DB00273
?:topiramate_does_not_inhibit_cyp2a6?:DB00273
?:topiramate_does_not_inhibit_cyp2b6?:DB00273
?:topiramate_does_not_inhibit_cyp2c19?:DB00273
?:topiramate_does_not_inhibit_cyp2c9?:DB00273
?:topiramate_does_not_inhibit_cyp2d6?:DB00273
?:topiramate_does_not_inhibit_cyp2e1?:DB00273
?:topiramate_does_not_inhibit_cyp3a4?:DB00273
?:topiramate_does_not_inhibit_cyp3a5?:DB00273
?:topiramate_inhibits_cyp1a2?:DB00273
?:topiramate_inhibits_cyp2a6?:DB00273
?:topiramate_inhibits_cyp2b6?:DB00273
?:topiramate_inhibits_cyp2c19?:DB00273
?:topiramate_inhibits_cyp2c9?:DB00273
?:topiramate_inhibits_cyp2d6?:DB00273
?:topiramate_inhibits_cyp2e1?:DB00273
?:topiramate_inhibits_cyp3a4?:DB00273
?:topiramate_inhibits_cyp3a5?:DB00273
?:topiramate_primary_total_clearance_mechanism_Renal_Excretion?:DB00273
?:trazodone_bioavailability_continuous_value?:DB00656
?:trazodone_has_metabolite_M-chlorophenylpiperazine?:DB00656
?:trazodone_is_not_substrate_of_cyp3a4?:DB00656
?:trazodone_maximum_concentration_continuous_value?:DB00656
?:trazodone_primary_total_clearance_mechanism_Renal_Excretion?:DB00656
?:trazodone_substrate_of_cyp3a4?:DB00656
?:triazolam_in_vitro_probe_substrate_of_enzyme_cyp3a4?:DB00897
?:triazolam_increases_auc_nefazodone?:DB00897
?:triazolam_primary_total_clearance_enzyme_cyp3a4?:DB00897
?:trimethoprim_does_not_inhibit_cyp2c8?:DB00440
?:trimethoprim_inhibits_cyp2c8?:DB00440
?:troleandomycin_in_vitro_selective_inhibitor_of_enzyme_cyp3a4?:DB01361
?:venlafaxine_does_not_inhibit_cyp1a2?:DB00285
?:venlafaxine_does_not_inhibit_cyp2c9?:DB00285
?:venlafaxine_does_not_inhibit_cyp2d6?:DB00285
?:venlafaxine_does_not_inhibit_cyp3a4?:DB00285
?:venlafaxine_fraction_absorbed_continuous_value?:DB00285
?:venlafaxine_has_metabolite_N-desmethylvenlafaxine?:DB00285
?:venlafaxine_has_metabolite_O-desmethylvenlafaxine?:DB00285
?:venlafaxine_increases_auc_9-hydroxyrisperidone?:DB00285
?:venlafaxine_increases_auc_alprazolam?:DB00285
?:venlafaxine_increases_auc_desipramine?:DB00285
?:venlafaxine_increases_auc_haloperidol?:DB00285
?:venlafaxine_increases_auc_imipramine?:DB00285
?:venlafaxine_increases_auc_risperidone?:DB00285
?:venlafaxine_inhibits_cyp1a2?:DB00285
?:venlafaxine_inhibits_cyp2c9?:DB00285
?:venlafaxine_inhibits_cyp2d6?:DB00285
?:venlafaxine_inhibits_cyp3a4?:DB00285
?:venlafaxine_is_not_substrate_of_cyp2d6?:DB00285
?:venlafaxine_is_not_substrate_of_cyp3a4?:DB00285
?:venlafaxine_maximum_concentration_continuous_value?:DB00285
?:venlafaxine_primary_total_clearance_enzyme_cyp2d6?:DB00285
?:venlafaxine_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00285
?:venlafaxine_substrate_of_cyp2d6?:DB00285
?:venlafaxine_substrate_of_cyp3a4?:DB00285
?:verapamil_does_not_inhibit_cyp1a2?:DB00661
?:verapamil_does_not_inhibit_cyp3a4?:DB00661
?:verapamil_does_not_inhibit_cyp3a5?:DB00661
?:verapamil_increases_auc_imipramine?:DB00661
?:verapamil_increases_auc_risperidone?:DB00661
?:verapamil_inhibits_cyp1a2?:DB00661
?:verapamil_inhibits_cyp3a4?:DB00661
?:verapamil_inhibits_cyp3a5?:DB00661
?:voriconazole_bioavailability_continuous_value?:DB00582
?:voriconazole_does_not_inhibit_cyp2c19?:DB00582
?:voriconazole_does_not_inhibit_cyp2c9?:DB00582
?:voriconazole_does_not_inhibit_cyp3a4?:DB00582
?:voriconazole_has_metabolite_voriconazole-N-oxide?:DB00582
?:voriconazole_inhibits_cyp2c19?:DB00582
?:voriconazole_inhibits_cyp2c9?:DB00582
?:voriconazole_inhibits_cyp3a4?:DB00582
?:voriconazole_is_not_substrate_of_cyp2c19?:DB00582
?:voriconazole_is_not_substrate_of_cyp2c9?:DB00582
?:voriconazole_is_not_substrate_of_cyp3a4?:DB00582
?:voriconazole_maximum_concentration_continuous_value?:DB00582
?:voriconazole_primary_total_clearance_enzyme_cyp2c19?:DB00582
?:voriconazole_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00582
?:voriconazole_substrate_of_cyp2c19?:DB00582
?:voriconazole_substrate_of_cyp2c9?:DB00582
?:voriconazole_substrate_of_cyp3a4?:DB00582
?:warfarin_primary_total_clearance_enzyme_cyp2c9?:DB00682
?:zafirlukast_does_not_inhibit_cyp2c9?:DB00549
?:zafirlukast_does_not_inhibit_cyp3a4?:DB00549
?:zafirlukast_inhibits_cyp2c9?:DB00549
?:zafirlukast_inhibits_cyp3a4?:DB00549
?:zafirlukast_is_not_substrate_of_cyp2c9?:DB00549
?:zafirlukast_maximum_concentration_continuous_value?:DB00549
?:zafirlukast_substrate_of_cyp2c9?:DB00549
?:zaleplon_bioavailability_continuous_value?:DB00962
?:zaleplon_is_not_substrate_of_cyp2d6?:DB00962
?:zaleplon_is_not_substrate_of_cyp3a4?:DB00962
?:zaleplon_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00962
?:zaleplon_substrate_of_cyp2d6?:DB00962
?:zaleplon_substrate_of_cyp3a4?:DB00962
?:ziprasidone_does_not_inhibit_cyp1a2?:DB00246
?:ziprasidone_does_not_inhibit_cyp2c19?:DB00246
?:ziprasidone_does_not_inhibit_cyp2c9?:DB00246
?:ziprasidone_does_not_inhibit_cyp2d6?:DB00246
?:ziprasidone_does_not_inhibit_cyp3a4?:DB00246
?:ziprasidone_has_metabolite_S-methyl-dihydroziprasidone?:DB00246
?:ziprasidone_has_metabolite_benzisothiazole-sulphone?:DB00246
?:ziprasidone_has_metabolite_benzisothiazole-sulphoxide?:DB00246
?:ziprasidone_has_metabolite_ziprasidone-sulphoxide?:DB00246
?:ziprasidone_inhibition_constant_cyp2d6?:DB00246
?:ziprasidone_inhibits_cyp1a2?:DB00246
?:ziprasidone_inhibits_cyp2c19?:DB00246
?:ziprasidone_inhibits_cyp2c9?:DB00246
?:ziprasidone_inhibits_cyp2d6?:DB00246
?:ziprasidone_inhibits_cyp3a4?:DB00246
?:ziprasidone_is_not_substrate_of_cyp1a2?:DB00246
?:ziprasidone_is_not_substrate_of_cyp2c19?:DB00246
?:ziprasidone_is_not_substrate_of_cyp2c9?:DB00246
?:ziprasidone_is_not_substrate_of_cyp2d6?:DB00246
?:ziprasidone_is_not_substrate_of_cyp3a4?:DB00246
?:ziprasidone_maximum_concentration_continuous_value?:DB00246
?:ziprasidone_primary_total_clearance_mechanism_Metabolic_Clearance?:DB00246
?:ziprasidone_substrate_of_cyp1a2?:DB00246
?:ziprasidone_substrate_of_cyp2c19?:DB00246
?:ziprasidone_substrate_of_cyp2c9?:DB00246
?:ziprasidone_substrate_of_cyp2d6?:DB00246
?:ziprasidone_substrate_of_cyp3a4?:DB00246
?:zolpidem_is_not_substrate_of_cyp3a4?:DB00425
?:zolpidem_is_not_substrate_of_cyp3a5?:DB00425
?:zolpidem_maximum_concentration_continuous_value?:DB00425
?:zolpidem_substrate_of_cyp3a4?:DB00425
?:zolpidem_substrate_of_cyp3a5?:DB00425